Loading
No insider purchase over the last 90 days. The latest was filed 03 Mar 2021.
Insider filings for Calliditas Therapeutics AB are scarce in the Finansinspektionen feed, the latest one published on 3 March 2021. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
· cache
1 of 1 declaration
Calliditas Therapeutics AB is a biopharmaceutical company focused on developing treatments for rare kidney diseases. It is listed on the XSTO stock exchange.